Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19
2020-05-27 20:07
AFT Pharmaceuticals Donates Almost $110,000 To Health Charities When They Need It Most
2020-05-26 08:46
Nucleus Network commences Novavax' Phase 1/2 COVID-19 vaccine trial in Australia
2020-05-26 08:41
Innovent Announces First Patient Dosed in A Phase 1 Clinical Trial of Anti-TIGIT Monoclonal Antibody in China
2020-05-26 07:30
New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks
2020-05-25 08:18
Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport
2020-05-22 13:00
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
2020-05-22 07:11
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme
2020-05-21 20:00
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
2020-05-21 14:00
Macrogen obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT'
2020-05-21 10:03
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
2020-05-21 08:58
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
2020-05-21 04:45
China Biologic Reports Financial Results for the First Quarter of 2020
2020-05-21 04:30
Macrogen Approved for Export of its COVID-19 Test Kit
2020-05-20 21:00
Marketing Authorization Application for Luye Pharma's Rivastigmine Multi-Day Transdermal Patch Product Rivalif® under Review at EU Competent Authorities
2020-05-20 19:34
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
2020-05-20 19:00
I-Mab Expands Global Presence with New Hong Kong Office
2020-05-20 16:00
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification
2020-05-20 07:11
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
2020-05-19 19:00
Zai Lab Announces First Chinese Patient Dosed in the Global Phase 3 ATTACK Trial of Sulbactam- Durlobactam for Patients with Carbapenem-Resistant Acinetobacter Infections
2020-05-19 09:45
1
294
295
296
297
298
412